Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lot Quality Assurance Sampling | 8 | 2015 | 17 | 2.850 |
Why?
|
Disease Outbreaks | 13 | 2021 | 1762 | 1.510 |
Why?
|
Schistosoma mansoni | 3 | 2012 | 155 | 0.860 |
Why?
|
Schistosomiasis mansoni | 2 | 2012 | 93 | 0.790 |
Why?
|
Cluster Analysis | 8 | 2015 | 2711 | 0.680 |
Why?
|
Space-Time Clustering | 2 | 2009 | 46 | 0.640 |
Why?
|
Quality Assurance, Health Care | 5 | 2015 | 2167 | 0.620 |
Why?
|
Sentinel Surveillance | 3 | 2011 | 292 | 0.620 |
Why?
|
Program Evaluation | 5 | 2018 | 2493 | 0.620 |
Why?
|
Poliomyelitis | 2 | 2018 | 92 | 0.580 |
Why?
|
Population Surveillance | 6 | 2014 | 2603 | 0.580 |
Why?
|
Influenza, Human | 4 | 2013 | 1517 | 0.540 |
Why?
|
Parasite Egg Count | 2 | 2012 | 29 | 0.530 |
Why?
|
Basic Reproduction Number | 2 | 2021 | 35 | 0.530 |
Why?
|
Sampling Studies | 2 | 2015 | 615 | 0.520 |
Why?
|
Drug Resistance, Viral | 2 | 2013 | 861 | 0.490 |
Why?
|
Entropy | 1 | 2015 | 210 | 0.480 |
Why?
|
Bayes Theorem | 2 | 2013 | 2326 | 0.480 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 2691 | 0.470 |
Why?
|
HIV-1 | 4 | 2015 | 6859 | 0.410 |
Why?
|
Mass Vaccination | 1 | 2014 | 109 | 0.410 |
Why?
|
Data Collection | 3 | 2014 | 3321 | 0.410 |
Why?
|
Tuberculosis, Pulmonary | 4 | 2016 | 831 | 0.390 |
Why?
|
Crime Victims | 1 | 2015 | 347 | 0.370 |
Why?
|
Health Surveys | 3 | 2015 | 4056 | 0.360 |
Why?
|
Computer Simulation | 9 | 2018 | 6230 | 0.340 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2012 | 445 | 0.340 |
Why?
|
Public Sector | 2 | 2012 | 267 | 0.330 |
Why?
|
Biostatistics | 1 | 2011 | 164 | 0.330 |
Why?
|
HIV Infections | 6 | 2015 | 17328 | 0.320 |
Why?
|
Tuberculosis, Multidrug-Resistant | 5 | 2016 | 931 | 0.320 |
Why?
|
Immunization | 1 | 2013 | 1226 | 0.310 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1336 | 0.310 |
Why?
|
Topography, Medical | 1 | 2007 | 37 | 0.300 |
Why?
|
Firearms | 1 | 2015 | 625 | 0.290 |
Why?
|
Disease Transmission, Infectious | 1 | 2013 | 557 | 0.290 |
Why?
|
Leukemia | 2 | 2014 | 1522 | 0.290 |
Why?
|
Research Design | 2 | 2021 | 6168 | 0.280 |
Why?
|
Health Care Surveys | 1 | 2014 | 2425 | 0.270 |
Why?
|
Sample Size | 3 | 2015 | 839 | 0.260 |
Why?
|
Health Status Indicators | 1 | 2011 | 968 | 0.250 |
Why?
|
HIV | 1 | 2012 | 1582 | 0.250 |
Why?
|
Epidemiologic Measurements | 1 | 2004 | 23 | 0.240 |
Why?
|
Prevalence | 10 | 2022 | 15698 | 0.230 |
Why?
|
Models, Statistical | 6 | 2015 | 5078 | 0.230 |
Why?
|
Drug Resistance, Bacterial | 1 | 2010 | 1058 | 0.210 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1998 | 0.200 |
Why?
|
Health Status | 1 | 2015 | 4071 | 0.200 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5332 | 0.190 |
Why?
|
DNA, Viral | 1 | 2007 | 2201 | 0.170 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2002 | 406 | 0.170 |
Why?
|
Anti-HIV Agents | 2 | 2013 | 4518 | 0.170 |
Why?
|
Humans | 52 | 2022 | 760437 | 0.170 |
Why?
|
Phylogeny | 1 | 2007 | 2806 | 0.170 |
Why?
|
Antitubercular Agents | 3 | 2016 | 1374 | 0.160 |
Why?
|
Infant, Premature, Diseases | 2 | 2002 | 710 | 0.160 |
Why?
|
Pandemics | 3 | 2020 | 8623 | 0.160 |
Why?
|
Statistics as Topic | 1 | 2005 | 2357 | 0.160 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1891 | 0.150 |
Why?
|
Infant, Extremely Low Birth Weight | 2 | 2009 | 83 | 0.150 |
Why?
|
Algorithms | 6 | 2015 | 14002 | 0.150 |
Why?
|
New York | 2 | 2014 | 872 | 0.150 |
Why?
|
Likelihood Functions | 2 | 2013 | 990 | 0.140 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2002 | 497 | 0.140 |
Why?
|
Models, Genetic | 1 | 2007 | 3445 | 0.140 |
Why?
|
Mass Screening | 1 | 2012 | 5424 | 0.140 |
Why?
|
Chronic Disease | 2 | 2011 | 9309 | 0.140 |
Why?
|
Echoencephalography | 3 | 2008 | 134 | 0.130 |
Why?
|
Infection Control | 2 | 2015 | 985 | 0.130 |
Why?
|
Environmental Exposure | 1 | 2011 | 4443 | 0.130 |
Why?
|
Morbidity | 1 | 2021 | 1750 | 0.130 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14661 | 0.120 |
Why?
|
Ventilation | 1 | 2015 | 128 | 0.120 |
Why?
|
Geographic Information Systems | 2 | 2014 | 281 | 0.120 |
Why?
|
Rifampin | 1 | 2016 | 339 | 0.120 |
Why?
|
Prenatal Care | 1 | 2022 | 1134 | 0.110 |
Why?
|
Florida | 1 | 2015 | 431 | 0.110 |
Why?
|
Cerebral Palsy | 2 | 2009 | 473 | 0.110 |
Why?
|
Local Government | 1 | 2014 | 81 | 0.110 |
Why?
|
Disinfection | 1 | 2015 | 210 | 0.110 |
Why?
|
Child Health Services | 1 | 2018 | 645 | 0.110 |
Why?
|
Residence Characteristics | 2 | 2015 | 2087 | 0.110 |
Why?
|
Africa, Eastern | 1 | 2012 | 76 | 0.100 |
Why?
|
Measles Vaccine | 1 | 2013 | 80 | 0.100 |
Why?
|
Anthelmintics | 1 | 2012 | 82 | 0.100 |
Why?
|
United Nations | 1 | 2013 | 150 | 0.100 |
Why?
|
Regression Analysis | 2 | 2015 | 6340 | 0.100 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2656 | 0.100 |
Why?
|
Health Services Research | 1 | 2018 | 1811 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2015 | 3576 | 0.090 |
Why?
|
Total Quality Management | 1 | 2012 | 264 | 0.090 |
Why?
|
South Africa | 2 | 2013 | 1840 | 0.090 |
Why?
|
Nigeria | 1 | 2014 | 770 | 0.090 |
Why?
|
Uganda | 1 | 2015 | 1332 | 0.090 |
Why?
|
Micronutrients | 1 | 2013 | 381 | 0.090 |
Why?
|
Mosquito Nets | 1 | 2010 | 9 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1079 | 0.090 |
Why?
|
Chemoprevention | 1 | 2012 | 326 | 0.090 |
Why?
|
Culex | 1 | 2009 | 18 | 0.090 |
Why?
|
Cost Control | 1 | 2012 | 628 | 0.090 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1668 | 0.090 |
Why?
|
Developmental Disabilities | 2 | 2009 | 1508 | 0.080 |
Why?
|
Masks | 1 | 2012 | 208 | 0.080 |
Why?
|
West Nile Fever | 1 | 2009 | 74 | 0.080 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2013 | 369 | 0.080 |
Why?
|
Insect Vectors | 1 | 2009 | 135 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2022 | 26280 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3331 | 0.080 |
Why?
|
Uncertainty | 1 | 2013 | 753 | 0.070 |
Why?
|
Incidence | 3 | 2015 | 21322 | 0.070 |
Why?
|
Urban Population | 1 | 2015 | 2032 | 0.070 |
Why?
|
Infant | 5 | 2018 | 36183 | 0.070 |
Why?
|
Child | 6 | 2018 | 80086 | 0.070 |
Why?
|
Child, Preschool | 6 | 2018 | 42209 | 0.070 |
Why?
|
Cleft Lip | 1 | 2012 | 506 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 831 | 0.070 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.070 |
Why?
|
Software | 1 | 2021 | 4426 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1315 | 0.070 |
Why?
|
Cleft Palate | 1 | 2012 | 589 | 0.070 |
Why?
|
Demography | 3 | 2009 | 1648 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3375 | 0.070 |
Why?
|
Iron | 1 | 2013 | 1787 | 0.060 |
Why?
|
Rural Population | 1 | 2015 | 2279 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2098 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15257 | 0.060 |
Why?
|
Male | 12 | 2016 | 360035 | 0.060 |
Why?
|
Sputum | 2 | 2016 | 506 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 471 | 0.060 |
Why?
|
India | 1 | 2010 | 2341 | 0.050 |
Why?
|
Psychomotor Performance | 2 | 2009 | 1880 | 0.050 |
Why?
|
Female | 15 | 2022 | 391875 | 0.050 |
Why?
|
Confidentiality | 1 | 2007 | 609 | 0.050 |
Why?
|
Head | 1 | 2009 | 924 | 0.050 |
Why?
|
Weight Gain | 1 | 2013 | 2346 | 0.050 |
Why?
|
Selection Bias | 1 | 2004 | 359 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1781 | 0.050 |
Why?
|
Tuberculosis | 1 | 2015 | 2012 | 0.050 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.050 |
Why?
|
Triplets | 1 | 2002 | 43 | 0.050 |
Why?
|
Guinea Pigs | 2 | 2015 | 1317 | 0.050 |
Why?
|
ROC Curve | 1 | 2010 | 3571 | 0.050 |
Why?
|
Patient Admission | 1 | 2009 | 1367 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2009 | 842 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3923 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6908 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2002 | 267 | 0.050 |
Why?
|
Chorioamnionitis | 1 | 2002 | 156 | 0.050 |
Why?
|
Leukomalacia, Periventricular | 1 | 2002 | 184 | 0.040 |
Why?
|
Twins | 1 | 2002 | 339 | 0.040 |
Why?
|
Malaria | 1 | 2010 | 1225 | 0.040 |
Why?
|
Computational Biology | 2 | 2013 | 3510 | 0.040 |
Why?
|
Adult | 8 | 2016 | 220781 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2002 | 387 | 0.040 |
Why?
|
Public Health | 1 | 2013 | 2665 | 0.040 |
Why?
|
History, 20th Century | 1 | 2008 | 2770 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2005 | 1257 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10180 | 0.040 |
Why?
|
Gestational Age | 1 | 2008 | 3574 | 0.040 |
Why?
|
Animals | 6 | 2015 | 168253 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1544 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26063 | 0.040 |
Why?
|
Adolescent | 4 | 2015 | 88196 | 0.040 |
Why?
|
Madagascar | 1 | 2018 | 110 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4108 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 2 | 2016 | 1952 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 64591 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 1010 | 0.040 |
Why?
|
Child Development | 1 | 2008 | 2302 | 0.030 |
Why?
|
Massachusetts | 1 | 2009 | 8826 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2002 | 913 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4735 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 268 | 0.030 |
Why?
|
Hypotension | 1 | 2002 | 879 | 0.030 |
Why?
|
Placenta | 2 | 2002 | 1704 | 0.030 |
Why?
|
Genetic Variation | 2 | 2009 | 6570 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2009 | 916 | 0.030 |
Why?
|
Tuberculin Test | 1 | 2015 | 206 | 0.030 |
Why?
|
Uzbekistan | 1 | 2013 | 1 | 0.030 |
Why?
|
Bread | 1 | 2013 | 23 | 0.030 |
Why?
|
Flour | 1 | 2013 | 21 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 628 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 2 | 2016 | 1912 | 0.030 |
Why?
|
Pregnancy | 4 | 2022 | 29831 | 0.030 |
Why?
|
Folic Acid Deficiency | 1 | 2013 | 117 | 0.030 |
Why?
|
Organization and Administration | 1 | 2012 | 54 | 0.030 |
Why?
|
Food, Fortified | 1 | 2013 | 189 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2002 | 1428 | 0.020 |
Why?
|
Lung Diseases | 1 | 2002 | 1909 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1923 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9462 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1703 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 304 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 361 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2002 | 2916 | 0.020 |
Why?
|
Critical Care | 1 | 2003 | 2697 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 598 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2642 | 0.020 |
Why?
|
Mozambique | 1 | 2010 | 55 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3742 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3764 | 0.020 |
Why?
|
Insecticide-Treated Bednets | 1 | 2010 | 68 | 0.020 |
Why?
|
Middle Aged | 5 | 2016 | 220382 | 0.020 |
Why?
|
Private Sector | 1 | 2012 | 397 | 0.020 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2012 | 249 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 74055 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 59068 | 0.020 |
Why?
|
Peru | 1 | 2012 | 890 | 0.020 |
Why?
|
Certification | 1 | 2012 | 418 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4010 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30025 | 0.020 |
Why?
|
Hemiplegia | 1 | 2008 | 136 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1524 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 587 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2009 | 785 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13240 | 0.020 |
Why?
|
Risk Assessment | 2 | 2014 | 23953 | 0.020 |
Why?
|
United States | 3 | 2009 | 72202 | 0.020 |
Why?
|
Quadriplegia | 1 | 2008 | 226 | 0.020 |
Why?
|
Feces | 1 | 2013 | 1494 | 0.020 |
Why?
|
Cohort Studies | 3 | 2016 | 41366 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6471 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1045 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2003 | 5421 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3637 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9605 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10759 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2119 | 0.010 |
Why?
|
Microcephaly | 1 | 2008 | 425 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2927 | 0.010 |
Why?
|
Geography | 1 | 2005 | 658 | 0.010 |
Why?
|
Public Health Administration | 1 | 2005 | 243 | 0.010 |
Why?
|
Cost of Illness | 1 | 2012 | 1931 | 0.010 |
Why?
|
Ureaplasma | 1 | 2002 | 60 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 20078 | 0.010 |
Why?
|
Infant, Premature | 2 | 2002 | 2104 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2217 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12429 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 773 | 0.010 |
Why?
|
Brain | 2 | 2012 | 27060 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2517 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 2002 | 2622 | 0.010 |
Why?
|
Italy | 1 | 2002 | 840 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 818 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2003 | 443 | 0.010 |
Why?
|
Motor Activity | 1 | 2009 | 2710 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2002 | 12054 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12976 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 973 | 0.010 |
Why?
|
Gastrectomy | 1 | 2002 | 671 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8216 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7208 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5966 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2003 | 1403 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2912 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2005 | 2771 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2008 | 39078 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2003 | 1859 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10746 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10494 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12653 | 0.010 |
Why?
|
Prospective Studies | 2 | 2012 | 54339 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12969 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1918 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 80430 | 0.010 |
Why?
|
Cognition | 1 | 2008 | 6973 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39947 | 0.010 |
Why?
|
Boston | 1 | 2003 | 9326 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10075 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 10538 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12698 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 2002 | 2946 | 0.000 |
Why?
|
Sepsis | 1 | 2002 | 2583 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 7860 | 0.000 |
Why?
|
Age Factors | 1 | 2002 | 18379 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2002 | 22097 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29551 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36362 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2002 | 58859 | 0.000 |
Why?
|
Aged | 1 | 2002 | 168840 | 0.000 |
Why?
|